33

11 Second-line erlotinib in unselected NSCLC: audit of benefit

Year:
2011
Language:
english
File:
PDF, 34 KB
english, 2011
47

18 NSCLC second line therapy with erlotinib: review of patients' outcomes

Year:
2011
Language:
english
File:
PDF, 34 KB
english, 2011
49

Letter

Year:
1997
Language:
english
File:
PDF, 239 KB
english, 1997